HBV-话题@MedSci

#HBV#

159篇内容 | 6474人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1836661, encodeId=fa491836661b2, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, objectType=article, longId=138064, objectId=bdd0138064e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdd0138064e2, replyNumber=0, likeNumber=74, createdTime=2018-12-19, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdd0138064e2, moduleTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdd0138064e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836668, encodeId=80781836668b0, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, objectType=article, longId=145196, objectId=e18514519623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18514519623, replyNumber=0, likeNumber=88, createdTime=2019-05-07, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18514519623, moduleTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18514519623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836654, encodeId=9c271836654c6, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型, objectType=article, longId=132044, objectId=d3a81320444c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a81320444c, replyNumber=0, likeNumber=76, createdTime=2018-04-20, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a81320444c, moduleTitle=J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a81320444c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836657, encodeId=fbfe183665e84, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=异常凝血酶原检测超早期发现HBV感染者肝细胞癌1例, objectType=article, longId=134213, objectId=c1861342132b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1861342132b, replyNumber=0, likeNumber=138, createdTime=2018-11-05, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1861342132b, moduleTitle=异常凝血酶原检测超早期发现HBV感染者肝细胞癌1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1861342132b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836652, encodeId=d6cd183665228, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Gastroenterology：在HBV-HCV共感染细胞，HBV并没有阻止IFN对HCV复制的抑制作用, objectType=article, longId=129622, objectId=32f312962272, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f312962272, replyNumber=0, likeNumber=72, createdTime=2018-10-20, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f312962272, moduleTitle=Gastroenterology：在HBV-HCV共感染细胞，HBV并没有阻止IFN对HCV复制的抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f312962272)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836653, encodeId=81a11836653e7, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=NEJM：替诺福韦降低HBV母婴传播风险, objectType=article, longId=131831, objectId=74ef131831fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ef131831fc, replyNumber=0, likeNumber=93, createdTime=2018-12-02, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ef131831fc, moduleTitle=NEJM：替诺福韦降低HBV母婴传播风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74ef131831fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836658, encodeId=5499183665857, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Hepatol：检测隐匿性乙型肝炎感染新的方法：液滴数字PCR法检测HBc抗体阳性患者肝供体中的HBV cccDNA水平, objectType=article, longId=134874, objectId=5a701348e44c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a701348e44c, replyNumber=0, likeNumber=0, createdTime=2018-09-19, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a701348e44c, moduleTitle=J Hepatol：检测隐匿性乙型肝炎感染新的方法：液滴数字PCR法检测HBc抗体阳性患者肝供体中的HBV cccDNA水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a701348e44c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836655, encodeId=3128183665534, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Ann Surg：在血清HBV DNA载量较低的患者中，抗病毒治疗减少了肝细胞癌复发, objectType=article, longId=132220, objectId=47ea132220d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47ea132220d6, replyNumber=0, likeNumber=0, createdTime=2018-07-03, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47ea132220d6, moduleTitle=Ann Surg：在血清HBV DNA载量较低的患者中，抗病毒治疗减少了肝细胞癌复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47ea132220d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836656, encodeId=95b61836656c2, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Viral Hepat：既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险, objectType=article, longId=133820, objectId=d2d11338202c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2d11338202c, replyNumber=0, likeNumber=80, createdTime=2018-04-07, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2d11338202c, moduleTitle=J Viral Hepat：既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2d11338202c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836651, encodeId=2c2a183665178, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Viral Hepat：采用Paritaprevir/Ombitasvir/Ritonavir, Dasabuvir和Ribavirin等药物治疗HBV和H, objectType=article, longId=129423, objectId=33a2129423ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a2129423ba, replyNumber=0, likeNumber=77, createdTime=2018-08-17, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a2129423ba, moduleTitle=J Viral Hepat：采用Paritaprevir/Ombitasvir/Ritonavir, Dasabuvir和Ribavirin等药物治疗HBV和H, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a2129423ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836673, encodeId=7b2f18366e3cf, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：中科大田志刚教授团队揭示以天然免疫为主导的HBV相关肝癌发病机制, objectType=article, longId=152843, objectId=7c6f15284349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c6f15284349, replyNumber=0, likeNumber=84, createdTime=2019-05-13, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c6f15284349, moduleTitle=Hepatology：中科大田志刚教授团队揭示以天然免疫为主导的HBV相关肝癌发病机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c6f15284349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836642, encodeId=a9a318366423d, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Gastroenterol Hepatol：HBV核心相关抗原水平能够预测乙肝病毒携带者的肝硬化进展, objectType=article, longId=121609, objectId=d40b1216098a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d40b1216098a, replyNumber=0, likeNumber=78, createdTime=2018-09-18, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d40b1216098a, moduleTitle=J Gastroenterol Hepatol：HBV核心相关抗原水平能够预测乙肝病毒携带者的肝硬化进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d40b1216098a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836636, encodeId=6d37183663617, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Exp Clin Cancer Res：研究揭示HBV促进肝细胞癌发生的机制, objectType=article, longId=118905, objectId=d44311890511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d44311890511, replyNumber=0, likeNumber=87, createdTime=2018-06-16, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d44311890511, moduleTitle=J Exp Clin Cancer Res：研究揭示HBV促进肝细胞癌发生的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d44311890511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836663, encodeId=b3c2183666313, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Liver Int：治疗26周时的肝脏硬度可以预测HBV相关代偿性肝硬化患者的2年预后结果, objectType=article, longId=140302, objectId=29f2140302e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29f2140302e7, replyNumber=0, likeNumber=81, createdTime=2018-12-20, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29f2140302e7, moduleTitle=Liver Int：治疗26周时的肝脏硬度可以预测HBV相关代偿性肝硬化患者的2年预后结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29f2140302e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836666, encodeId=b0721836666c3, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology:微生物所叶昕研究组在HBV上调的lnc-HUR1调控肝癌发生的机制方面取得进展, objectType=article, longId=144618, objectId=fa2114461867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa2114461867, replyNumber=0, likeNumber=92, createdTime=2018-08-09, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa2114461867, moduleTitle=Hepatology:微生物所叶昕研究组在HBV上调的lnc-HUR1调控肝癌发生的机制方面取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa2114461867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836640, encodeId=7fe61836640fe, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Hepatol：接受肝切除术后抗病毒治疗能够提高存在HBV感染的胆管细胞癌患者的生存率, objectType=article, longId=121372, objectId=ca191213e264, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca191213e264, replyNumber=0, likeNumber=95, createdTime=2018-04-03, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca191213e264, moduleTitle=J Hepatol：接受肝切除术后抗病毒治疗能够提高存在HBV感染的胆管细胞癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca191213e264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836646, encodeId=3a32183664634, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=检查乙肝，两对半就够了，拿这HBV DNA有何用？, objectType=article, longId=126002, objectId=52c5126002ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52c5126002ee, replyNumber=0, likeNumber=78, createdTime=2018-04-04, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52c5126002ee, moduleTitle=检查乙肝，两对半就够了，拿这HBV DNA有何用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52c5126002ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836665, encodeId=ba8918366659e, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【获奖案例】HBsAg阴性，HBV-DNA阳性, objectType=article, longId=142878, objectId=30201428e862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30201428e862, replyNumber=0, likeNumber=101, createdTime=2018-12-04, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30201428e862, moduleTitle=【获奖案例】HBsAg阴性，HBV-DNA阳性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30201428e862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836662, encodeId=34b318366623d, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Gastroenterol Hepatol：HCV、HBV双感染阻断了血小板计数的恢复，尤其是在晚期肝纤维化患者中, objectType=article, longId=138360, objectId=810b138360f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810b138360f6, replyNumber=0, likeNumber=83, createdTime=2018-06-26, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810b138360f6, moduleTitle=J Gastroenterol Hepatol：HCV、HBV双感染阻断了血小板计数的恢复，尤其是在晚期肝纤维化患者中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810b138360f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836645, encodeId=c2171836645b8, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：HBV pgRNA可用于乙肝相关肝癌的肿瘤分型和预后预测, objectType=article, longId=125494, objectId=a3e9125494ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3e9125494ea, replyNumber=0, likeNumber=86, createdTime=2018-06-18, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3e9125494ea, moduleTitle=Hepatology：HBV pgRNA可用于乙肝相关肝癌的肿瘤分型和预后预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3e9125494ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBV

2020-05-29

klivis (审核中...)

前往app查看评论内容

#HBV#

Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险

2018-12-19

klivis (审核中...)

前往app查看评论内容

#HBV#

J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险

2019-05-07

klivis (审核中...)

前往app查看评论内容

#HBV#

J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型

2018-04-20

klivis (审核中...)

前往app查看评论内容

#HBV#

异常凝血酶原检测超早期发现HBV感染者肝细胞癌1例

2018-11-05

klivis (审核中...)

前往app查看评论内容

#HBV#

Gastroenterology：在HBV-HCV共感染细胞，HBV并没有阻止IFN对HCV复制的抑制作用

2018-10-20

klivis (审核中...)

前往app查看评论内容

#HBV#

NEJM：替诺福韦降低HBV母婴传播风险

2018-12-02

klivis (审核中...)

前往app查看评论内容

#HBV#

J Hepatol：检测隐匿性乙型肝炎感染新的方法：液滴数字PCR法检测HBc抗体阳性患者肝供体中的HBV cccDNA水平

2018-09-19

klivis (审核中...)

前往app查看评论内容

#HBV#

Ann Surg：在血清HBV DNA载量较低的患者中，抗病毒治疗减少了肝细胞癌复发

2018-07-03

klivis (审核中...)

前往app查看评论内容

#HBV#

J Viral Hepat：既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险

2018-04-07

klivis (审核中...)

前往app查看评论内容

#HBV#

J Viral Hepat：采用Paritaprevir/Ombitasvir/Ritonavir, Dasabuvir和Ribavirin等药物治疗HBV和H

2018-08-17

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：中科大田志刚教授团队揭示以天然免疫为主导的HBV相关肝癌发病机制

2019-05-13

klivis (审核中...)

前往app查看评论内容

#HBV#

J Gastroenterol Hepatol：HBV核心相关抗原水平能够预测乙肝病毒携带者的肝硬化进展

2018-09-18

klivis (审核中...)

前往app查看评论内容

#HBV#

J Exp Clin Cancer Res：研究揭示HBV促进肝细胞癌发生的机制

2018-06-16

klivis (审核中...)

前往app查看评论内容

#HBV#

Liver Int：治疗26周时的肝脏硬度可以预测HBV相关代偿性肝硬化患者的2年预后结果

2018-12-20

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology:微生物所叶昕研究组在HBV上调的lnc-HUR1调控肝癌发生的机制方面取得进展

2018-08-09

klivis (审核中...)

前往app查看评论内容

#HBV#

J Hepatol：接受肝切除术后抗病毒治疗能够提高存在HBV感染的胆管细胞癌患者的生存率

2018-04-03

klivis (审核中...)

前往app查看评论内容

#HBV#

检查乙肝，两对半就够了，拿这HBV DNA有何用？

2018-04-04

klivis (审核中...)

前往app查看评论内容

#HBV#

【获奖案例】HBsAg阴性，HBV-DNA阳性

2018-12-04

klivis (审核中...)

前往app查看评论内容

#HBV#

J Gastroenterol Hepatol：HCV、HBV双感染阻断了血小板计数的恢复，尤其是在晚期肝纤维化患者中

2018-06-26

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：HBV pgRNA可用于乙肝相关肝癌的肿瘤分型和预后预测

2018-06-18

科室
- - 订阅+
  - 更多科室
工具
服务